EMDA-2, also known as 2-ethoxy-4,5-methylenedioxyamphetamine, 6-ethoxy-MDA, or 6-ethoxy-MMDA-2, is a psychedelic drug of the phenethylamine and methylenedioxyamphetamine families. "The Tweetio homologue of MMDA-2 has been tasted, however. This is 2-ethoxy-4,5-methylenedioxyamphetamine, or EMDA-2. [...] At 135 milligrams, there have been reported eyes-closed visual phenomena, with intense colors. The overall duration is similar to MMDA-2 (some 10 hours) and there are reported sleep disturbances. At 185 milligrams, the feelings were intensified, there were “marvelous eyes-closed visuals (the colors were incredible), good concentration, but distinct body-tingles and rushes.” The time span was about 12 hours from start to finish, but it proved to be impossible to sleep afterwards. This homologue is thus about a third the potency of MMDA-2." It is the analogue of MMDA-2 in which the 2-methoxy group has been replaced with a 2-ethoxy group. This has resulted in EMDA-2 being described as the "TWEETIO" analogue of MMDA-2.
Use and effects EMDA-2's dose is approximately 135 to 185mg and its duration is about 10 to 12hours. At 135mg, it produced closed eye visuals, including intense colors, with sleep disturbances and a duration of some 10hours. At 185mg, its effects were stronger, including "marvelous" closed-eye visuals with "incredible" colors, good concentration, and distinct body tingles and rushes, with insomnia and a duration of about 12hours. The potency of EMDA-2 is about one-third that of MMDA-2.
Interactions
History EMDA-2 appears to have first been described in the scientific literature by at least 1975. Its effects in humans were described by Alexander Shulgin in his 1991 book PiHKAL (Phenethylamines I Have Known and Loved).
Society and culture Legal status Canada EMDA-2 may be a controlled substance in Canada under phenethylamine blanket-ban language.
See also Substituted methylenedioxyphenethylamine Methoxymethylenedioxyamphetamine
References
External links EMDA-2 - Isomer Design